Literature DB >> 9053811

Neuron-like physiological properties of cells from human oligodendroglial tumors.

S Patt1, C Labrakakis, M Bernstein, P Weydt, J Cervós-Navarro, G Nisch, H Kettenmann.   

Abstract

One of the most common symptoms of patients with oligodendrogliomas is the high frequency of epileptic seizures. We thus studied the physiological properties of cells in six human oligodendrogliomas and two oligoastrocytomas obtained from surgical material. The majority of tumor cells in living brain slices can generate action potentials as recorded with the patch-clamp technique indicating that this tissue is dominated by electrically excitable cells. In cultures from the same material, the action potential generating cells prevail within the first days and are subsequently replaced by electrically inexcitable cells. From histopathological and immunohistochemical data, the histogenesis of human oligodendroglial tumor is still uncertain. Our physiological study has not settled the debate on the origin of these tumors but revealed important findings with regard to this question. Since action potential generating glial cells have not been described in situ so far their occurrence in oligodendroglial tumors implies that oligodendroglial tumor cells may belong to the neuronal cell lineage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9053811     DOI: 10.1016/0306-4522(95)00468-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

Review 1.  Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2007-08-28       Impact factor: 5.864

2.  Relations between intracellular Ca2+ stores and store-operated Ca2+ entry in primary cultured human glioblastoma cells.

Authors:  J Hartmann; A Verkhratsky
Journal:  J Physiol       Date:  1998-12-01       Impact factor: 5.182

Review 3.  Glutamate transporters in the biology of malignant gliomas.

Authors:  Stephanie M Robert; Harald Sontheimer
Journal:  Cell Mol Life Sci       Date:  2013-11-27       Impact factor: 9.261

4.  Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall.

Authors:  Arie Perry; Stephanie S Burton; Gregory N Fuller; Christopher A Robinson; Cheryl A Palmer; Lothar Resch; Eileen H Bigio; Meena Gujrati; Marc K Rosenblum
Journal:  Acta Neuropathol       Date:  2010-05-13       Impact factor: 17.088

5.  Human central neurocytoma cells show neuronal physiological properties in vitro.

Authors:  S Patt; H Schmidt; C Labrakakis; P Weydt; M Fritsch; J Cervós-Navarro; H Kettenmann
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

6.  Epidermal growth factor upregulates motility of Mat-LyLu rat prostate cancer cells partially via voltage-gated Na+ channel activity.

Authors:  Yanning Ding; William J Brackenbury; Pinar U Onganer; Ximena Montano; Louise M Porter; Lucy F Bates; Mustafa B A Djamgoz
Journal:  J Cell Physiol       Date:  2008-04       Impact factor: 6.384

7.  Prognostic significance of neuronal marker expression in glioblastomas.

Authors:  Kyung-Hwa Lee; Kyung-Joo Kang; Kyung-Sub Moon; Tae-Young Jung; Shin Jung; Jae-Hyoo Kim; Hyung-Seok Kim; Min-Cheol Lee
Journal:  Childs Nerv Syst       Date:  2012-08-26       Impact factor: 1.475

Review 8.  How big is the myelinating orchestra? Cellular diversity within the oligodendrocyte lineage: facts and hypotheses.

Authors:  Giulio Srubek Tomassy; Valentina Fossati
Journal:  Front Cell Neurosci       Date:  2014-07-28       Impact factor: 5.505

9.  Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter.

Authors:  Ragnhildur Káradóttir; Nicola B Hamilton; Yamina Bakiri; David Attwell
Journal:  Nat Neurosci       Date:  2008-03-02       Impact factor: 24.884

Review 10.  Peritumoral epilepsy: relating form and function for surgical success.

Authors:  Christopher J A Cowie; Mark O Cunningham
Journal:  Epilepsy Behav       Date:  2014-06-02       Impact factor: 2.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.